XML 59 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments $ 1,093,338,000   $ 1,093,338,000   $ 1,087,377,000
Other assets 12,537,000   12,537,000   32,944,000
Other liabilities 19,248,000   19,248,000   28,213,000
Debt 1,135,216,000   1,135,216,000   1,384,105,000
Long-term debt, fair value 1,234,253,000   1,234,253,000   1,468,618,000
Net investment income | Other investments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Net unrealized gains recognized in earnings 15,600,000 $ (2,700,000) (44,500,000) $ (1,400,000)  
Other income (loss) | Other assets and (liabilities)          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Net unrealized gains recognized in earnings 0 $ 0 0 $ 0  
Fair Value, Measurements, Recurring          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments 1,093,338,000   1,093,338,000   1,087,377,000
Other assets         21,668,000
Other liabilities 2,636,000   2,636,000    
Fair Value, Measurements, Recurring | Private equity investments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments 254,257,000   254,257,000   271,047,000
Fair Value, Measurements, Recurring | Assumed and ceded (re)insurance contracts          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other assets         4,731,000
Other liabilities 6,711,000   6,711,000    
Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments 71,450,000   71,450,000   74,634,000
Other assets         4,731,000
Other liabilities 6,711,000   6,711,000    
Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Private equity investments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments 71,450,000   71,450,000   74,634,000
Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Assumed and ceded (re)insurance contracts          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other assets         $ 4,731,000
Other liabilities 6,711,000   6,711,000    
Significant Unobservable Inputs (Level 3) | External valuation model | Fair Value, Measurements, Recurring | Private equity investments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments 1,143,000   1,143,000    
Significant Unobservable Inputs (Level 3) | Internal valuation model | Fair Value, Measurements, Recurring | Private equity investments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other investments 70,307,000   70,307,000    
Significant Unobservable Inputs (Level 3) | Internal valuation model | Fair Value, Measurements, Recurring | Assumed and ceded (re)insurance contracts          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other liabilities 1,400,000   1,400,000    
Significant Unobservable Inputs (Level 3) | Internal valuation model | Fair Value, Measurements, Recurring | Assumed reinsurance contract          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other liabilities 8,232,000   8,232,000    
Significant Unobservable Inputs (Level 3) | Internal valuation model | Fair Value, Measurements, Recurring | Assumed and ceded (re)insurance contract          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Other assets 2,963,000   2,963,000    
Fair Value Measured at Net Asset Value Per Share          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Miscellaneous other investments $ 214,726,000   $ 214,726,000    
U.S. treasuries          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 0.30%   0.30%   1.70%
Agencies          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 0.70%   0.70%   2.10%
Non-U.S. government          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 0.70%   0.70%   1.60%
Non-U.S. government-backed corporate          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 0.80%   0.80%   2.00%
Corporate          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 2.70%   2.70%   3.00%
Agency mortgage-backed          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 1.00%   1.00%   2.50%
Weighted average life     3 years 2 months 12 days   4 years 10 months 24 days
Non-agency prime residential mortgage-backed          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 3.10%   3.10%   3.30%
Weighted average life     4 years 9 months 18 days   4 years 9 months 18 days
Alt-A non-agency mortgage-backed          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 3.70%   3.70%   3.80%
Weighted average life     6 years 1 month 6 days   6 years 3 months 18 days
Commercial mortgage-backed          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 2.00%   2.00%   2.60%
Weighted average life     5 years 6 months   5 years 8 months 12 days
Asset-backed          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 2.50%   2.50%   3.30%
Weighted average life     3 years   3 years 2 months 12 days
Short term investments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Weighted average effective yield 0.20%   0.20%   1.60%
Private equity investments | Minimum          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Liquidation period for fund assets     7 years    
Private equity investments | Maximum          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Liquidation period for fund assets     10 years    
Private equity investments | Fair Value Measured at Net Asset Value Per Share          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Miscellaneous other investments $ 182,807,000   $ 182,807,000    
Senior secured bank loan funds          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Miscellaneous other investments 22,300,000   $ 22,300,000    
Senior secured bank loan funds | Minimum          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Liquidation period for fund assets     4 years    
Senior secured bank loan funds | Maximum          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Liquidation period for fund assets     5 years    
Senior secured bank loan funds | Fair Value Measured at Net Asset Value Per Share          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Miscellaneous other investments 22,261,000   $ 22,261,000    
Hedge funds | Fair Value Measured at Net Asset Value Per Share          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Miscellaneous other investments $ 9,658,000   $ 9,658,000